Extensive HCP Access and Research Coverage Across Psoriasis, Eczema, Melanoma, and Other Key Skin Conditions
Konovo’s Dermatology Therapeutic Breakdown provides a comprehensive analysis of global market research capabilities in dermatology, supported by insights from 475 projects and 34,362 respondent completes over the past three years. Our verified panel of 2 million+ healthcare professionals includes dermatologists, primary care physicians, internal medicine specialists, nurse practitioners, and physician assistants, with reach across the Americas, Europe, and Asia. We deliver detailed incidence rates and research coverage across eczema/atopic dermatitis, psoriasis, plaque psoriasis, psoriatic arthritis, rosacea, melanoma, and hidradenitis suppurativa. Backed by proprietary recruitment technologies and rigorous quality controls, Konovo ensures representative, high-quality dermatology market data that empowers pharmaceutical, biotech, and medtech companies to make faster, evidence-based decisions.
